Comorbidities in lung cancer progression

P. Schnabel (Homburg/Saar, Germany), N. Kahn (Heidelberg, Germany)

Source: International Congress 2017 – ME12 Comorbidities in lung cancer progression
Session: ME12 Comorbidities in lung cancer progression
Session type: Meet the expert
Number: 4327

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Schnabel (Homburg/Saar, Germany), N. Kahn (Heidelberg, Germany). Comorbidities in lung cancer progression. International Congress 2017 – ME12 Comorbidities in lung cancer progression

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016



Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005

Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Risk factors for lung cancer in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Accompanying diseases in lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006

Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008


Efficacy of osimertinib and histomolecular profile at progression in EGFR-mutated lung cancer
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007

Smoking and lung cancer
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018

Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


Smoking status, COPD and lung cancer surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005

The burden of emphysema on lung cancer prognosis
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020

Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002

Predictors of major serious manifestations in the terminal stage of lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Anemia during lung cancer
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018